ATOSSA THERAPEUTICS, INC. Finite-Lived Intangible Asset, Expected Amortization, Year One
ATOSSA THERAPEUTICS, INC. (ATOS) had Finite-Lived Intangible Asset, Expected Amortization, Year One of $25.35 thousand as of 2017-12-31, per its 10-K filed 2018-03-08.
Discontinued › Notes › Goodwill and Other › Intangible Asset, Finite-Lived, after Accumulated Amortization, Estimated Amortization Expense, Fiscal Year Maturity
us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths · last filed 2018-03-08
- 2017-12-31: Finite-Lived Intangible Asset, Expected Amortization, Year One $25.35K.
- 2017-09-30: Finite-Lived Intangible Asset, Expected Amortization, Year One $23.95K.
- 2017-06-30: Finite-Lived Intangible Asset, Expected Amortization, Year One $48.28K.
- 2017-03-31: Finite-Lived Intangible Asset, Expected Amortization, Year One $72.61K.
| Period end | Finite-Lived Intangible Asset, Expected Amortization, Year One |
|---|---|
| 2017-12-31 | $25.35K 10-K · filed 2018-03-08 |
| 2017-09-30 | $23.95K 10-Q · filed 2017-11-13 |
| 2017-06-30 | $48.28K 10-Q · filed 2017-08-14 |
| 2017-03-31 | $72.61K 10-Q · filed 2017-05-11 |
| 2016-12-31 | $90.85K 10-K/A · filed 2017-03-21 |
| 2016-09-30 | $42.49K 10-Q/A · filed 2017-03-21 |
| 2016-06-30 | $87.60K 10-Q/A · filed 2017-03-21 |
| 2016-03-31 | $132.71K 10-Q/A · filed 2017-03-21 |
| 2015-12-31 | $216.11K 10-K · filed 2016-03-30 |
| 2015-09-30 | $53.52K 10-Q · filed 2015-11-12 |
| 2015-06-30 | $107.03K 10-Q · filed 2015-08-06 |
| 2015-03-31 | $163.13K 10-Q · filed 2015-05-13 |
| 2014-12-31 | $213.78K 10-K · filed 2015-03-30 |
| 2014-09-30 | $110.22K 10-Q · filed 2014-11-12 |
| 2014-06-30 | $212.14K 10-Q · filed 2014-08-12 |
| 2014-03-31 | $313.52K 10-Q · filed 2014-05-14 |
| 2013-12-31 | $400.78K 10-K · filed 2014-03-27 |
| 2013-09-30 | $393.07K 10-Q · filed 2013-11-12 |
| 2013-06-30 | $382.68K 10-Q · filed 2013-08-14 |
| 2013-03-31 | $196.50K 10-Q · filed 2013-05-15 |
| 2012-12-31 | $374.42K 10-K · filed 2013-03-28 |
| 2012-09-30 | $376.84K 10-Q/A · filed 2013-01-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |